Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for men receiving methadone maintenance treatment
IRCT20231101059923N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) comparing Oxytocin with Placebo (2 arms). Primary endpoints: Craving, Sexual function and 1 more. Started Oct 2024; status: completed.
02
Drugs
oxytocin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20231101059923N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231101059923N1.